PL2237782T3 - Zastosowanie tetrahydropirymidyn - Google Patents

Zastosowanie tetrahydropirymidyn

Info

Publication number
PL2237782T3
PL2237782T3 PL09706015T PL09706015T PL2237782T3 PL 2237782 T3 PL2237782 T3 PL 2237782T3 PL 09706015 T PL09706015 T PL 09706015T PL 09706015 T PL09706015 T PL 09706015T PL 2237782 T3 PL2237782 T3 PL 2237782T3
Authority
PL
Poland
Prior art keywords
tetrahydropyrimidines
Prior art date
Application number
PL09706015T
Other languages
English (en)
Inventor
Rene Tolba
Gerhild Von Echten-Deckert
Georg Lentzen
Andreas Bilstein
Original Assignee
Bitop Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitop Ag filed Critical Bitop Ag
Publication of PL2237782T3 publication Critical patent/PL2237782T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
PL09706015T 2008-01-30 2009-01-30 Zastosowanie tetrahydropirymidyn PL2237782T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008006780A DE102008006780A1 (de) 2008-01-30 2008-01-30 Verwendung von Tetrahydropyrimidinen
PCT/EP2009/000641 WO2009095269A1 (de) 2008-01-30 2009-01-30 Verwendung von tetrahydropyrimidinen
EP09706015.6A EP2237782B1 (de) 2008-01-30 2009-01-30 Verwendung von tetrahydropyrimidinen

Publications (1)

Publication Number Publication Date
PL2237782T3 true PL2237782T3 (pl) 2018-12-31

Family

ID=40568610

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09706015T PL2237782T3 (pl) 2008-01-30 2009-01-30 Zastosowanie tetrahydropirymidyn

Country Status (8)

Country Link
US (1) US20110269784A1 (pl)
EP (1) EP2237782B1 (pl)
JP (1) JP2011510944A (pl)
DE (1) DE102008006780A1 (pl)
ES (1) ES2676599T3 (pl)
PL (1) PL2237782T3 (pl)
TR (1) TR201809819T4 (pl)
WO (1) WO2009095269A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160106747A1 (en) * 2008-01-30 2016-04-21 Bitop Ag Treating postoperative mechanical stress with an ectoine
CN102210685B (zh) * 2011-04-29 2013-01-30 济南环肽医药科技有限公司 四氢嘧啶及其衍生物在制备预防和治疗化疗药物引发的口腔粘膜炎药物中的应用
DE102012005177A1 (de) 2012-03-16 2013-09-19 Bitop Ag Organlagerlösung
WO2019193717A1 (ja) * 2018-04-05 2019-10-10 株式会社資生堂 Ａｓｍｔ発現促進剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4244580A1 (de) * 1992-12-31 1994-07-07 Galinski Erwin A Verfahren zur in vivo Gewinnung von Inhaltsstoffen aus Zellen
DE4342560A1 (de) * 1993-12-14 1995-06-22 Marbert Gmbh Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
SE9601396D0 (sv) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 2
PT101887A (pt) * 1996-06-28 1998-01-30 Inst De Biolog Ex E Tecnologic Utilizacao de 2-0- -manosilglicerato para termoestabilizacao, osmoproteccao e proteccao contra a desidratacao de enzimas, outros componenetes celulares e celulas
ATE247981T1 (de) * 1999-06-12 2003-09-15 Bitop Ag Proteinenthaltende pharmazeutische zubereitung
DE10006578C2 (de) * 2000-02-14 2002-10-31 Bitop Ag Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren
DE10014632A1 (de) * 2000-03-24 2001-09-27 Merck Patent Gmbh Verwendung von Ectoin oder Ectoin-Derivaten zum Schutz der Streßproteine in der Haut
DE10330243A1 (de) * 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
DE10330768A1 (de) * 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung
DE102004016129A1 (de) * 2004-03-31 2005-10-20 Bitop Ag Topische Zubereitung zur Anwendung auf der Haut enthaltend natürliches Öl der Nachtkerze (Oenothera biennis) (=Oleum Oenotherae) und Osmolyte aus extremophilen Mikroorganismen
US9089568B2 (en) * 2005-03-12 2015-07-28 Bitop Ag Method of using compatible solutes containing ectoine and/or hydroxyectoine

Also Published As

Publication number Publication date
WO2009095269A1 (de) 2009-08-06
EP2237782B1 (de) 2018-04-11
ES2676599T3 (es) 2018-07-23
EP2237782A1 (de) 2010-10-13
TR201809819T4 (tr) 2018-07-23
US20110269784A1 (en) 2011-11-03
DE102008006780A1 (de) 2009-08-06
JP2011510944A (ja) 2011-04-07

Similar Documents

Publication Publication Date Title
HRP20181370T1 (hr) Heterociklični spoj i njegova uporaba
HK1172896A1 (zh) 化合物和使用方法
HK1161094A1 (en) Compounds and methods of use
GB0807612D0 (en) New use of surfactant
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
PL2328545T3 (pl) Zastosowanie glukozyloglicerolu
PL2133419T3 (pl) Zastosowania beta-dipeptydów cyjanoficyny
EP2455380A4 (en) Heterocyclic compound and its use
HK1160925A1 (zh) 組織蛋白酶 的用途
GB0812012D0 (en) Use
GB0816459D0 (en) State of change estimate
EP2399921A4 (en) HETEROCYCLIC COMPOUND AND APPLICATIONS
PL2237782T3 (pl) Zastosowanie tetrahydropirymidyn
HK1131039A1 (en) Pharmaceutical use of sophoricoside
GB0703514D0 (en) Use of riboflavin
GB0807621D0 (en) Use
HK1157387A1 (en) Use of hsa-producing cells
GB201114396D0 (en) Location of basesation
HU0800656D0 (en) Effective use of tea-composition
GB0821710D0 (en) Derivatives of dihydroindolone
GB0810045D0 (en) Use
GB0807996D0 (en) Use
GB0813119D0 (en) Use
PL383759A1 (pl) Nowe zastosowanie undekan-2-olu
PL383760A1 (pl) Nowe zastosowanie undekan-2-olu